Live tape
Top 8, mentions 7d10,913GOOGL2,081 mentions▲ +0.04SNDK1,536 mentions▲ +0.11SPCX1,501 mentions▲ +0.08NBIS1,429 mentions▲ +0.10HTZ1,239 mentions▲ +0.10NVDA1,212 mentions▲ +0.08META1,065 mentions▲ +0.03MSFT850 mentions▲ +0.06

Equity · Healthcare

TFX

Teleflex Incorporated · NYSE

$134.68 −0.24% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 40 sessions
$140 $120 20 May 17 Jul

The line runs $135.17 on 20 May through $134.68 on 17 July, on a scale from $120 to $140. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of TFX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 40 sessions over that window: $135.17 on 20 May 2026 through $134.68 on 17 July 2026.

Market cap $5.7B
52-week range $100 – $140.91
Avg volume 113.9K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

TFX insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 8 Jun 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 3

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
08 Jun 2026 RANDLE STUART A Director Award 5,658
08 Jun 2026 Weidman Jason R. President and CEO Award 53,983
07 Jun 2026 RANDLE STUART A Director Tax withheld 4,054 $526K

TFX reported financials

SEC EDGAR XBRL

TFX reported revenue of $2.0B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$905.6M.

Figure Reported Period
Revenue $2.0B 31 Dec 2025 fiscal year
Net income −$905.6M 31 Dec 2025 fiscal year
Diluted EPS −$20.25 31 Dec 2025 fiscal year
Total assets $6.8B 30 Jun 2026 at period end
Total equity $2.9B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

TFX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $2.28 $570M
31 Mar 2026 Q1 2026 $-0.18 $548M
31 Dec 2025 FY 2025 $-16.15 $569M
28 Sep 2025 FY 2025 $-9.24 $567M
29 Jun 2025 FY 2025 $2.77 $443M
30 Mar 2025 Q1 2025 $2.07 $414M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

TFX institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a TFX position for the quarter ended 30 Jun 2026 — a combined $596.3M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Millennium Management Added +111.4% shares 1,442,103 $182.8M
Baupost Group Held (±25%) −11.7% shares 1,409,000 $178.6M
Citadel Advisors Held (±25%) −2.6% shares 1,140,950 $144.6M
Balyasny Asset Management Held (±25%) −21.5% shares 315,212 $40.0M
AQR Capital Management Added +90.6% shares 280,637 $35.2M
Renaissance Technologies Added +33.5% shares 75,700 $9.6M
Marshall Wace New position 17,106 $2.2M
D. E. Shaw & Co. Trimmed −88.5% shares 13,409 $1.7M
Man Group Added +131.4% shares 13,297 $1.7M
Point72 Asset Management Exited

Source: SEC EDGAR 13F filings

TFX fails-to-deliver

SEC CNS data

On 31 Jul 2026, 433 shares of TFX failed to deliver (about $57K).

Settlement date Shares failed Notional % of shares out
31 Jul 2026 433 $57K 0.001%
22 Jul 2026 49 $7K <0.001%
16 Jul 2026 10,279 $1.4M 0.024%
15 Jul 2026 30 $4K <0.001%
14 Jul 2026 333 $45K 0.001%

Source: SEC fails-to-deliver (CNS) data